Industry News
Pharmaceutical Industry News
Boston Faces Identity Crisis Amid Trump’s Cuts to University and Research Funding
Colleges and teaching hospitals are the cornerstones of the city’s economy — and identity. But federal funding cuts to higher education could change that.
Trump Rejects Proposal for Medicare to Cover Wegovy and Other Obesity Drugs
Administration officials reversed a decision made during the Biden presidency that would have given millions of people access to weight-loss drugs paid for Medicare and Medicaid.
Trump’s Next Tariffs Target Could be Foreign-Made Pharmaceuticals
President Trump wants to bring pharmaceutical manufacturing back to the United States. Experts warn that tariffs could result in shortages and higher prices for generic drugs.
FDA Layoffs Could Raise Drug Costs and Erode Food Safety
Trump cutbacks were supposedly aimed at administrators. But scientists in food and drug-testing labs and policy experts who advance generic drug approvals were also dismissed.
La derecha en EE. UU. sigue defendiendo a la ivermectina
El fármaco se ha convertido en una especie de símbolo de resistencia a lo que algunos en el movimiento MAGA describen como una élite corrupta.
Why the Right Still Embraces Ivermectin
Five years after the pandemic began, interest in the anti-parasitic drug is rising again as right-wing influencers promote it — and spread misinformation about it.
Isomorphic Labs, Google’s A.I. Drug Business, Raises Money From Thrive
The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital as a backer.
Lo que hay que saber sobre el Adderall, Ritalin y otros estimulantes
El secretario de Salud, Robert F. Kennedy Jr., los ha calificado de veneno, pero los médicos afirman que los estimulantes de venta controlada ayudan a millones de personas.
Eli Lilly Drug Reduces Mysterious Lp(a) Particle Involved in Heart Attack Risk
The Eli Lilly drug caused a major drop in the blood levels of Lp(a), but further research is needed to show that it will prevent heart attacks and strokes.
Is the Poppers Party Over?
A potential crackdown on a readily available party drug seems to be afoot. But don’t panic just yet.
For John Green, It’s Tuberculosis All the Way Down
The best-selling author “got a little emotional” while talking with The Times about the world’s deadliest infectious disease. Listen to the conversation.
What to Know About Adderall, Ritalin and Other Prescription Stimulants
Health Secretary Robert F. Kennedy Jr. has called them poison, but doctors say prescription stimulants like Ritalin and Adderall help millions of people.
H.H.S. Scraps Studies of Vaccines and Treatments for Future Pandemics
Federal officials cited the end of the Covid-19 pandemic in halting the research. But much of the work was focused on preventing outbreaks of other pathogens.
Los médicos le dijeron que iba a morir, pero la IA le salvó la vida
Los científicos están utilizando el aprendizaje automático para encontrar nuevos tratamientos entre miles de medicamentos antiguos.
Una expaciente psiquiátrica lidera un movimiento para dejar los fármacos
Laura Delano se alejó de los tratamientos psicotrópicos que definieron parte de su juventud. Ahora espera crear una hoja de ruta que otros puedan seguir. Los profesionales consideran los riesgos.
Psychiatric Drugs: Getting Off vs. Staying On
A psychiatrist and a patient respond to an article in Science Times. Also: A plea to Congress; an upside-down definition of waste, fraud and abuse.
Drugs Have Uses We Can’t Imagine. He’s Using A.I. to Find Them.
Scientists are using machine learning to find new treatments among thousands of old medicines.
Book Review: ‘Unshrunk,’ by Laura Delano
In “Unshrunk,” Laura Delano chronicles her struggles with mental illness — and the endless parade of pills meant to treat it.
The Ex-Patients’ Club
Laura Delano walked away from the treatments that defined her teens and 20s. Now, she’s hoping to create a road map for others to follow.
How Much Should Weight Loss Drugs Like Wegovy and Zepbound Cost?
A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are now.